Company intelligence / Profile preview

IBSA Group

Lugano, Ticino, Switzerlandibsagroup.com ↗
Ownership
Private
Employees
~2300
Development stage
Commercial
01

Overview

IBSA has FDA-approved products including Tirosint and Tirosint-SOL for hypothyroidism treatment

Therapeutic areas
Endocrinology
Modalities
Small molecules (pharmaceuticals)
Industry
Biotech
02

Drug pipeline

26 assets

Tirosint-SOL

Approved

25 more assets in the full pipeline.

Beyond the preview

Go deeper on IBSA Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IBSA Group.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call